Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Other Accumulated Expenses for 3 consecutive years, with $675000.0 as the latest value for Q1 2025.

  • Quarterly Other Accumulated Expenses changed N/A to $675000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $675000.0 through Mar 2025, changed N/A year-over-year, with the annual reading at $5.4 million for FY2023, N/A changed from the prior year.
  • Other Accumulated Expenses hit $675000.0 in Q1 2025 for Eton Pharmaceuticals, down from $4.9 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $5.4 million in Q4 2023 to a low of $675000.0 in Q1 2025.
  • Historically, Other Accumulated Expenses has averaged $3.6 million across 3 years, with a median of $4.9 million in 2024.